Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOFAcitinib in Patients With Early Onset SARS-CoV2 Interstitial Pneumonia

NCT04332042 is registered in ClinicalTrials.gov with Università Politecnica delle Marche as lead sponsor.

NCT NCT04332042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04332042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOFAcitinib in Patients With Early Onset SARS-CoV2 Interstitial Pneumonia
Lead sponsor
Università Politecnica delle Marche
Phase
Phase 2
Overall status
Unknown status
Start date
April 10, 2020
Completion date
July 10, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 related interstitial pneumonia